Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 8 Prostatic Neoplasms 7 Leukemia, Myeloid, Acute 6 Colorectal Neoplasms 5 Breast Neoplasms 5 Stomach Neoplasms 4 Leukemia, Myelomonocytic, Acute 4 Leukemia, Monocytic, Acute 4 Leukemia, Megakaryoblastic, Acute 4 Leukemia, Erythroblastic, Acute 4 Congenital Abnormalities 4 Pancreatic Neoplasms 3 Multiple Myeloma 3 Lymphoma, Mantle-Cell 3 Lung Neoplasms 3 Colonic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Venous Thromboembolism 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Papillomavirus Infections 2 Neuroblastoma 2 Neoplasm Metastasis 2 Motor Activity 2 Melanoma 2 Lymphoma, Follicular 2 Lymphoma 2 Leukemia, Eosinophilic, Acute 2 Leukemia, Basophilic, Acute 2

Interventions

talazoparib 1 olaparib 1 liposomal doxorubicin 1 Tranexamic Acid 1 Saline Solution 1 Observation 1 Neoadjuvant Therapy 1 Hyperthermic Intraperitoneal Chemotherapy 1 Carboplatin 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Ovarian Cancer × Observation × Clear all

NCT05775549 2024-09-20

FLAME

AstraZeneca

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡